MTI Outlook 2020: Medtechs Enter The Decade Of Digital, Consumers and Wellness

For health-care providers and medtech manufacturers alike, the decade ahead will require a coming to terms with digital technologies and integrating new methods of payment. Quality of service delivery remains the market-entry criterion, but companies will have to adapt to evolving health-care models. The stakes are high. Will manufacturers be able to capitalize on the changes in a market that is more competitive and unpredictable than ever?

Trends

“Digital is no longer a vertical, it cuts across all sectors. It is a horizontal.” Andy Fish, AdvaMed's chief strategy officer, was telling the press in late fall 2019 that medtech companies will come to incorporate digital as a means to an end, not as an end in itself. “Digital is now the coin of the realm,” he said, explaining the rationale behind the US industry association's decision to invest time and resources in a new Center For Digital Heath. (Also see "Reimbursement A Top Goal For New Digital Health Lobbying Center" - Medtech Insight, 18 October, 2019.)

More from Business

More from Medtech Insight

US Could Lose Its First Approver Advantage After FDA Layoffs

Mass FDA layoffs on 1 April were designed to spare product reviewers, but still touched many who are critical to the application review process or drug development, which could mean fewer treatments are brought to the US market first.

Staff Cuts At CDRH Focus On Administrative Workers, Spare Reviewers

 

About 200 staff in the FDA’s Center for Devices and Radiological Health were among the 3,500 FDA employees let go in today’s staff reductions. The cuts, which one employee described as a “Manhattan Project” to the center, are already having a major effect on staff morale.

Global Medtech Guidance Tracker: March 2025

 
• By 

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.